Press Releases
ProBioGen Delivers Strong 2022 Performance, Investing for Growth in 2023
read more ProBioGen Delivers Strong 2022 Performance, Investing for Growth in 2023
ProBioGen’s Growth Strategy Continues Successfully
read more ProBioGen’s Growth Strategy Continues Successfully
Another Clinical Asset Using ProBioGen's GlymaxX® Technology Begins Phase III
read more Another Clinical Asset Using ProBioGen's GlymaxX® Technology Begins Phase III
ProBioGen’s Vaccine Production Cell Line AGE1.CR.pIX® Used for Clinical Production
read more ProBioGen’s Vaccine Production Cell Line AGE1.CR.pIX® Used for Clinical Production
ProBioGen Collaborates with Boehringer Ingelheim on DirectedLuck® Transposase Technology
read more ProBioGen Collaborates with Boehringer Ingelheim on DirectedLuck® Transposase Technology
ProBioGen Co-Develops New Freedom™ ExpiCHO-S™ Cell Line Development Kit
read more ProBioGen Co-Develops New Freedom™ ExpiCHO-S™ Cell Line Development Kit
ProBioGen Celebrates "A New Dawn in Biotechnology"
read more ProBioGen Celebrates "A New Dawn in Biotechnology"
ProBioGen Receives Employer of the Future and Top Service Awards
read more ProBioGen Receives Employer of the Future and Top Service Awards
